This past week I attended the Cambridge Healthtech Institute’s “Applying Next Generation Sequencing” meeting in Providence R.I. Attendance was down which is an indicator of the maturity of NGS technology, constrained travel budgets, or an oversupply of NGS conferences, and probably a combination of all three.
Every mother-to-be who has what is considered an ‘at-risk’ pregnancy is informed of the risks to the fetus of a genetic abnormality. ‘At-risk’ can involve a long list of medical conditions (diabetes or cancer for example) or poor health choices (illegal drug use or smoking). Yet a common cause of […]